Oriola
1.138
EUR
-0.87 %
7,682 following
OKDBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Income statement
Valuation
Quarterly estimates
Income statement
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,552.2 | 1,721.3 | 1,800.8 | 1,882.4 | 1,841.4 | 1,493.8 | 1,679.7 | 1,807.1 | 1,894.2 | 1,982.3 | 2,074.5 |
growth-% | 10.9 % | 4.6 % | 4.5 % | -2.2 % | -18.9 % | 12.4 % | 7.6 % | 4.8 % | 4.6 % | 4.7 % | |
EBITDA | 53.3 | 60.6 | 63.1 | 65.4 | 68.6 | 30.1 | 27.2 | 27.3 | 29.3 | 34.0 | 38.9 |
EBIT (adj.) | 34.4 | 20.5 | 21.0 | 26.3 | 34.5 | 16.7 | 21.7 | 23.3 | 25.5 | 27.0 | 27.0 |
EBIT | 19.5 | 15.3 | 20.4 | 20.5 | 40.2 | -5.3 | 13.6 | 15.3 | 17.5 | 23.0 | 27.0 |
Profit before taxes | 16.6 | 10.1 | 14.3 | 14.7 | 35.4 | -17.6 | -18.6 | 7.1 | 12.5 | 22.6 | 26.6 |
Net income | 10.8 | 8.0 | 11.3 | 11.3 | 27.4 | -20.7 | -20.1 | 5.6 | 9.8 | 18.9 | 22.1 |
EPS (adj.) | 0.07 | 0.09 | 0.12 | 0.01 | -0.08 | 0.07 | 0.09 | 0.12 | 0.12 | ||
growth-% | 44.4 % | 26.9 % | -94.1 % | -1,178.8 % | 34.0 % | 37.6 % | 0.4 % | ||||
Dividend | 0.09 | 0.09 | 0.03 | 0.04 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Dividend ratio | 151.9 % | 204.5 % | 48.2 % | 64.2 % | 39.7 % | -61.2 % | -63.1 % | 226.3 % | 130.2 % | 67.2 % | 57.5 % |
Profitability and return on capital
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | 3.4 % | 3.5 % | 3.5 % | 3.5 % | 3.7 % | 2.0 % | 1.6 % | 1.5 % | 1.5 % | 1.7 % | 1.9 % |
EBIT-% (adj.) | 2.2 % | 1.2 % | 1.2 % | 1.4 % | 1.9 % | 1.1 % | 1.3 % | 1.3 % | 1.3 % | 1.4 % | 1.3 % |
EBIT-% | 1.3 % | 0.9 % | 1.1 % | 1.1 % | 2.2 % | -0.4 % | 0.8 % | 0.8 % | 0.9 % | 1.2 % | 1.3 % |
ROE | 4.8 % | 6.9 % | 5.8 % | 12.4 % | -10.4 % | -13.2 % | 4.3 % | 7.8 % | 14.9 % | 16.5 % | |
ROI | 4.7 % | 5.0 % | 4.6 % | 10.2 % | -3.1 % | -4.5 % | 6.2 % | 8.4 % | 13.3 % | 14.7 % |